Showing results (341-350 of 610) with videos related to

Sort By:
Pageof 61
Circulation|October 1, 1986
Synergism of thrombolytic agents in vivoD Collen, J M Stassen, D C Stump, et al.
Blood|February 1, 1987
Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activatorD C Stump, J M Stassen, E Demarsin, et al.
Blood|April 1, 1989
Thrombolytic properties of human tissue-type plasminogen activator, single-chain urokinase-type plasminogen activator, and synergistic combinations in venous thrombosis models in dogs and rabbitsD J Spriggs, J M Stassen, Y Hashimoto, et al.
Thrombosis and Haemostasis|December 27, 1982
Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivoD Collen, D C Rijken, J Van Damme, et al.
Analytical Biochemistry|August 1, 1997
Nonisotopic quantitative analysis of protein-DNA interactions at equilibriumA M Benotmane, M F Hoylaerts, D Collen, et al.
The Journal of Clinical Investigation|June 1, 1972
Metabolism of plasminogen in healthy subjects: effect of tranexamic acidD Collen, G Tytgat, H Claeys, et al.
Thrombosis and Haemostasis|January 23, 1991
Role of active center and lysine binding sites of plasmin in plasmin-induced platelet activation and disaggregationH Lu, C Soria, H Li, et al.
European Journal of Clinical Investigation|February 1, 1977
Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administrationD Collen, J Schetz, F de Cock, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 25, 1999
A fully functional deletion staphylokinase derivative crystallizes in two non-isomorphous monoclinic modificationsA Rabijns, H L De Bondt, D Collen, et al.
Thrombosis and Haemostasis|January 1, 1994
Prevalence and induction of circulating antibodies against recombinant staphylokinaseP J Declerck, S Vanderschueren, J Billiet, et al.
Pageof 61